# A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm

> **NCT06940804** · PHASE2 · WITHDRAWN · sponsor: **BioNTech SE**

## Conditions studied

- Testicular Germ Cell Tumor
- Extragonadal Germ Cell Tumor

## Interventions

- **BIOLOGICAL:** CLDN6 CAR-T
- **BIOLOGICAL:** CLDN6 RNA-LPX

## Key facts

- **NCT ID:** NCT06940804
- **Lead sponsor:** BioNTech SE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-07
- **Primary completion:** 2042-06
- **Final completion:** 2042-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06940804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06940804, "A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06940804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*